Enantiospecific synthesis of the phospholipase A2 inhibitor (-)-cinatrin B
- J Org Chem. 2002 Jun 28;67(13):4392-8. doi: 10.1021/jo016221k.
- 1. School of Chemistry, The University of Melbourne, Melbourne, Victoria 3010, Australia.
The first enantiospecific synthesis of Phospholipase A2 (PLA2) inhibitor (-)-cinatrin B (2) from the D-arabinose derivative 9 is described. The spirolactone system was formed by an Ireland-Claisen rearrangement of the allyl ester 8 followed by hydrolysis and stereoselective iodolactonization. The stereoselectivity of the rearrangement was controlled by the asymmetry in the allylic alcohol fragment. Ester (S)-8 gave the desired rearrangement product 7 and the epimer 13 in high yield as a 73:27 ratio, respectively. The final stereocenter at C2 was introduced via a chelation-controlled addition of the Grignard reagent derived from trimethylsilylacetylene to alpha-hydroxy ketone 6. Transformation of the terminal alkyne into the methyl ester 21 followed by acetal hydrolysis and selective lactol oxidation afforded cinatrin B methyl ester (22). Base hydrolysis and acid-induced relactonization then gave (-)-cinatrin B (2).
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: PhospholipaseResearch Areas: Infection